TRACON Pharmaceuticals Announces Reverse Stock Split
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a...
Source: globenewswire.com
📰 Product Development Platform News
Product Development Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Product Development Platform. Real-time updates on events, politics, business and more.
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue…
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals TCON,…
Source: biztoc.com
Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs
/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 907 million yen (US$6.2 million1) for the...
Source: prnewswire.com
Outer Selects Centric PLM™ as their Product Development Platform
CAMPBELL, Calif. (PRWEB) April 14, 2022 -- Outer, the eco-friendly outdoor furniture brand, has selected Centric Software®’s Product Lifecycle Management
Source: prweb.com
GHIT Fund Announces New Investments: A Total of 740 Million Yen for Malaria Drugs and Vaccine
/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 740 million yen (US$6.4 million*) to invest in...
Source: prnewswire.com
Whitepaper: How retailers can maximise private label profitability
How can retailers maximise Private Label profitability using an inclusive Product Development Platform to travel quickly from bright idea to store shelf?
Source: newfoodmagazine.com
GHIT Fund Announces New Investments: A Total of 750 Million Yen in Drugs for Malaria and Chagas Disease, Vaccine for Malaria, and Diagnostics for Tuberculosis
/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 750 million yen (US$6.6 million*) to invest in six...
Source: prnewswire.com
TRACON Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
TRACON Pharmaceuticals Announces Appointment of Carol Lam
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development...
Source: globenewswire.com